News

FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority

July 10, 2024 No Comments

USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section

June 20, 2024 No Comments

Patent Owners, Challengers Spar Over PTAB Rule Proposal

June 20, 2024 No Comments

USPTO Hears Array Of Ideas For Altering Director Review

June 18, 2024 No Comments

USPTO Extends Deadline for AI Inventorship Comments as Some Criticize Pannu Factors

June 9, 2024 No Comments

Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority

June 5, 2024 No Comments

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’

May 30, 2024 No Comments

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers

May 29, 2024 No Comments

Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans

May 28, 2024 No Comments

Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking

May 28, 2024 No Comments

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

May 23, 2024 No Comments

Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’

May 21, 2024 No Comments

FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority

July 10, 2024

USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section

June 20, 2024

Patent Owners, Challengers Spar Over PTAB Rule Proposal

June 20, 2024

USPTO Hears Array Of Ideas For Altering Director Review

June 18, 2024

USPTO Extends Deadline for AI Inventorship Comments as Some Criticize Pannu Factors

June 9, 2024

Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority

June 5, 2024

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’

May 30, 2024

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers

May 29, 2024

Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans

May 28, 2024

Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking

May 28, 2024

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

May 23, 2024

Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’

May 21, 2024

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

News

FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority

USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section

Patent Owners, Challengers Spar Over PTAB Rule Proposal

USPTO Hears Array Of Ideas For Altering Director Review

USPTO Extends Deadline for AI Inventorship Comments as Some Criticize Pannu Factors

Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers

Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans

Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’

FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority

USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section

Patent Owners, Challengers Spar Over PTAB Rule Proposal

USPTO Hears Array Of Ideas For Altering Director Review

USPTO Extends Deadline for AI Inventorship Comments as Some Criticize Pannu Factors

Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers

Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans

Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’

Contact

Menu